Research reportThe functional impact of subsyndromal depressive symptoms in bipolar disorder: Data from STEP-BD
Introduction
People with bipolar disorder have episodically impaired psychosocial functioning (Coryell et al., 1993, Bauwens et al., 1991, Gitlin et al., 1995, Bauer et al., 2001, Altshuler et al., 2002, Calabrese et al., 2003), and some degree of functional impairment is evident even during remissions (Cooke et al., 1996, Shapira et al., 1999, MacQueen et al., 2000). MacQueen et al. (2001) reported that up to 60% of individuals with bipolar disorder do not regain full functioning in occupational and social domains (MacQueen et al., 2001). Ongoing depressive symptoms are the strongest predictor of functional deficits in persons with bipolar disorder (Bauer et al., 2001, Judd et al., 2005). While recurring episodes of depression are clearly associated with poor outcomes, relatively less is known about the impact of subsyndromal depressive symptoms, or depressive symptoms of insufficient number, duration, and/or intensity to meet criteria for a full depressive mood episode. The presence of subsyndromal symptoms after resolution of a major affective episode is associated with increased risk for relapse (Perlis et al., 2006, Judd et al., 2008). The current investigation is concerned with the relationship of persistent subsyndromal symptoms to functional outcomes. Given that people with bipolar disorder spend approximately one third of their adult lives with depressive symptoms (Judd et al., 2002, Judd et al., 2003), the impact of depressive symptoms on functional outcomes is particularly relevant. In a study following patients for 2–4 years, almost half of those who did not experience full episodic relapse experienced significant affective symptoms. In contrast to relapse rates, a measure of cumulative affective morbidity was the strongest predictor of functional outcome in this study (Gitlin et al., 1995). Similarly, Bauer et al. (2001) reported that both number of weeks in a full depressive episode and average depression symptom score (including subsyndromal symptoms) were significantly related to functional outcomes. Two studies of euthymic patients in ongoing care demonstrated relationships between subsyndromal HAM-D scores and social adjustment (Shapira et al., 1999) and function (Cooke et al., 1996). A small study of 25 men with bipolar disorder indicated a relationship between subsyndromal depressive symptoms and function as measured by the GAF (Altshuler et al., 2002). In order to further elucidate the relationship between subsyndromal depressive symptoms, social and vocational function, and quality of life in bipolar disorder, we examined these variables in participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (“STEP-BD”; Sachs et al., 2003).
Section snippets
Methods
STEP-BD is a large, NIMH-funded longitudinal study that encompassed standardized assessments and treatments of adult outpatients with bipolar affective disorder. The methods of STEP-BD are described in detail elsewhere (Sachs et al., 2003); what follows is a summary of procedures relevant to the current report.
Sample characteristics at study entry
The patient population was predominantly Caucasian (90.6%). Fifty-seven percent were female, and 66% had bipolar I disorder. There was no difference in group membership related to diagnosis of bipolar I, bipolar II, or other diagnoses of bipolar disorder. There were some observed differences between groups on baseline characteristics, including mean duration of illness, relationship status, and education and income. Additionally, those in the recovered, subsyndromal, and depressed groups
Discussion
To our knowledge, this is the first investigation to examine baseline characteristics and prospective functional outcome across a large group of well-characterized patients with bipolar disorder experiencing sustained recovery, depressive episodes, and chronic subsyndromal symptoms.
Our findings are consistent with previous work that suggests that continued subsyndromal symptoms after a major depressive episode adversely affect functional recovery in patients with bipolar disorder (Gitlin et
Role of funding source
STEP-BD was funded with Federal funds from the National Institute of Mental Health (NIMH), National Institutes of Health, under Contract N01MH80001. The NIHM had no further role in study design; in the collection, analysis and interpretation of data, in the writing of the report, and in the decision to submit the paper for publication.
Conflict of interest
Since 11/19/07, Dr. Marangell has been employed by Eli Lilly and Company, and has stock ownership options in that company. Prior to 11/18/07, Dr. Marangell received grant/research support from Eli Lilly, Cyberonics, Bristol Myers Squib, Neuronetics, Stanley Foundation, Aspect Medical Systems, and Sanofi Aventis. She served as a consultant to Eli Lilly, Glaxo Smith Kline, Cyberonics, Pfizer, Medtronics, Forest, Aspect Medical Systems, and Novartis pharmaceuticals.
Dr. Dennehy is a consultant to
Acknowledgements
Dr. Marangell is now with Eli Lilly and Company, Indianapolis, IN. Any findings, opinions, and conclusions of this paper do not reflect the views or endorsement of Eli Lilly and Company. STEP-BD was funded with Federal funds from the National Institute of Mental Health (NIMH), National Institutes of Health, under Contract N01MH80001. Any opinions, findings, and conclusions or recommendations expressed in this publication are those of the authors and do not necessarily reflect the views of the
References (36)
- et al.
Determinants of functional outcome and healthcare costs in bipolar disorder: a high-intensity follow-up study
J. Affect. Disorders
(2001) - et al.
Well-being and functioning in patients with bipolar disorder assessed using the MOS 20-ITEM short form (SF-20)
J. Affect. Disorders
(1996) - et al.
Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)
Bio. Psychiatry
(2003) - et al.
Social adjustment and self-esteem in remitted patients with unipolar and bipolar affective disorder: a case-control study
Comp. Psychiatry
(1999) - et al.
Job performance deficits due to depression
Am. J. Psychiatry
(2006) - et al.
Subsyndromal depression is associated with functional impairment in patients with bipolar disorder
J. Clin. Psychiatry
(2002) - et al.
‘Bipolarity’ in bipolar disorder: distribution of manic and depressive symptoms in a treated population
British. J. Psychiatry
(2005) - et al.
Social adjustment of remitted bipolar and unipolar out-patients. A comparison with age- and sex-matched controls.
British J. Psychiatry
(1991) - et al.
Impact of bipolar disorder on a U.S. community sample
J. Clin. Psychiatry
(2003) - et al.
The enduring psychosocial consequences of mania and depression
Am. J. Psychiatry
(1993)
Revised NEO Personality Inventory (NEO PI-R) and the NEO Five-Factor Inventory (NEO-FFI) professional manual
Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure
Psychopharmacol. Bull.
Relapse and impairment in bipolar disorder
Am. J. Psychiatry
Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD
Am. J. Psychiatry
Anticonvulsant therapy and suicide risk in affective disorders
J. Clin. Psychiatry
Clinical features and function of patients with minor depression
Psychotherapy and Psychosomatic
The Personality Diagnostic Questionnaire: development and preliminary results
J. Personal. Dis.
A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders
Arch. Gen. Psychiatry
Cited by (0)
- 1
Dr. Marangell is now with Eli Lilly and Company, Indianapolis, IN, United States.